Page last updated: 2024-10-27

flurbiprofen and Local Neoplasm Recurrence

flurbiprofen has been researched along with Local Neoplasm Recurrence in 6 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
" Flurbiprofen did not seem to alter the bioavailability of the chemotherapeutic agents."1.26Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. ( Bennett, A; Berstock, DA; Carroll, MA, 1982)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Sakamaki, K1
Watanabe, K1
Woo, T1
Masuda, M1
Bennett, A5
Berstock, DA2
Carroll, MA1
Houghton, J2
Leaper, DJ3
French, B1
Stamford, IF1
French, BT1

Trials

1 trial available for flurbiprofen and Local Neoplasm Recurrence

ArticleYear
Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study.
    BMJ open, 2020, 11-30, Volume: 10, Issue:11

    Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Flurbiprofen; Humans; Japan; Lun

2020

Other Studies

5 other studies available for flurbiprofen and Local Neoplasm Recurrence

ArticleYear
Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
    British journal of cancer, 1982, Volume: 45, Issue:5

    Topics: Adenocarcinoma; Animals; Biological Availability; Body Weight; Drug Therapy, Combination; Female; Fl

1982
Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 6

    Topics: Adenocarcinoma; Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Mammary Neoplasms, Expe

1980
Reduction by flurbiprofen of primary tumor growth and local metastasis formation in mice.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 6

    Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental;

1980
Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.
    Prostaglandins, 1979, Volume: 17, Issue:2

    Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental;

1979
Breast cancer and prostaglandins: a new approach to treatment.
    The British journal of surgery, 1979, Volume: 66, Issue:10

    Topics: Animals; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Recurrence, Loc

1979